Bergenbio ASA (BGBIO) — Cash Flow-to-Debt Ratio
Latest as of December 2024:
-4.63x
Bergenbio ASA (BGBIO) has a Cash Flow-to-Debt Ratio of -4.63x as of December 2024, meaning its operating cash flow of Nkr-153.24 Million could theoretically repay -5% of its total liabilities (Nkr33.09 Million) in one year. Explore BGBIO cash generation efficiency to assess how effectively this company generates cash.
CF-to-Debt Ratio
-4.63x
Operating CF / Total Liabilities
Operating Cash Flow
Nkr-153.24 Million
NOK
Total Liabilities
Nkr33.09 Million
NOK
Data as of
Dec 2024
Most recent filing
Bergenbio ASA Cash Flow-to-Debt Ratio (2015–2024)
Historical debt coverage capacity for Bergenbio ASA across 10 annual periods. Also explore BGBIO asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Bergenbio ASA (2015–2024)
Year-by-year debt coverage analysis for Bergenbio ASA. For market capitalisation and broader financial context, see BGBIO market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (NOK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.63x | Nkr-153.24 Million | Nkr33.09 Million | ▲ +22.6% |
| 2023 | -5.99x | Nkr-280.50 Million | Nkr46.86 Million | ▼ -62.4% |
| 2022 | -3.69x | Nkr-288.23 Million | Nkr78.21 Million | ▲ +20.0% |
| 2021 | -4.61x | Nkr-303.34 Million | Nkr65.81 Million | ▼ -33.7% |
| 2020 | -3.45x | Nkr-234.29 Million | Nkr67.97 Million | ▲ +5.2% |
| 2019 | -3.64x | Nkr-184.15 Million | Nkr50.62 Million | ▲ +19.1% |
| 2018 | -4.49x | Nkr-186.71 Million | Nkr41.55 Million | ▲ +9.1% |
| 2017 | -4.95x | Nkr-168.11 Million | Nkr33.99 Million | ▲ +15.4% |
| 2016 | -5.85x | Nkr-124.31 Million | Nkr21.27 Million | ▼ -64.0% |
| 2015 | -3.56x | Nkr-62.90 Million | Nkr17.64 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.